Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Continued Access to Ceritinib for Cancer
Recruiting3 awardsPhase 4
Belleville, New Jersey
This trial will provide the drug ceritinib to patients who are already receiving it and who the investigator believes would benefit from continued treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service